ONLINE SYMPOSIUM

Innovations in Disease Modeling 2022

HELPING TO UNDERSTAND, DIAGNOSE AND TREAT DISEASE
Watch Now On-Demand
WhiteTwoLine

The first edition of this online symposium will provide industry and academic scientists with the opportunity to hear from experts within the field.

 Read More Below

Technology Spotlight Sponsors

Tech-Spotlight_V1

 

Standard Sponsors

Emulate Logo_Horizontal

 

 

 

 

Interested in sponsoring this online symposium? Contact our friendly sales team here

 

 

 

Online Symposium Summary

This inaugural online symposium will explore the tools and techniques being used to study diseases in the lab. Focus will be given to cell culture, organ-on-a-chip and organoid models, as well as, how innovations are enabling researchers to elucidate the underlying biological mechanisms of disease and support diagnostic and therapeutic development.

This online symposium will cover:

  • Novel human organ-on-a-chip technologies
  • Microscale sensors and systems
  • Synthetic 3D microenvironments
  • Self-organizing principles of human cardiogenesis
  • Human iPSC-derived cells in disease modeling
  • Platforms for generating CRISPR-edited cell models

View Full Agenda

 Keynote Speaker:

Donald E. Ingber, PhD
Donald E. Ingber, PhD
Founding Director
Wyss Institute for Biologically Inspired Engineering at Harvard University

 Speakers:

Mehmet R. Dokmeci, PhD
Mehmet R. Dokmeci, PhD
Associate Professor
Terasaki Institute for Biomedical Innovation
Lena Smirnova, PhD
Lena Smirnova, PhD
Research Associate
Johns Hopkins University, Center for Alternatives to Animal Testing
Sasha Mendjen, PhD
Sasha Mendjen, PhD
Group Leader
Institute of Molecular Biotechnology, Austria
Claus Jorgensen, PhD
Claus Jørgensen, PhD
Senior Group Leader
Cancer Research UK Manchester Institute, University of Manchester
Kevin Holden, PhD
Kevin Holden, PhD
Head of Science
Synthego
Kevin Holden, PhD
Steven Broadbent, PhD
Scientific Support Manager
Axol Bioscience Ltd
Alice Soragni, PhD
Alice Soragni, PhD
Assistant Professor
David Geffen School of Medicine at UCLA